• OPEN AN ACCOUNT
Indian Indices
Nifty
26,186.45 152.70
(0.59%)
Sensex
85,712.37 447.05
( 0.52%)
Bank Nifty
59,777.20 488.50
( 0.82%)
Nifty IT
38,703.65 343.40
( 0.90%)
Global Indices
Nasdaq
47,874.44 -29.46
(-0.06%)
Dow Jones
6,878.17 7.45
(0.11%)
Hang Seng
50,440.45 -587.97
(-1.15%)
Nikkei 225
9,722.32 30.25
(0.31%)
Forex
USD-INR
90.13 0.27
(0.30%)
EUR-INR
105.04 0.70
(0.67%)
GBP-INR
119.76 1.10
(0.93%)
JPY-INR
0.58 0.00
(0.57%)

EQUITY - MARKET SCREENER

EID Parry (India) Ltd
Industry :  Sugar
BSE Code
ISIN Demat
Book Value()
500125
INE126A01031
127.3510244
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EIDPARRY
0
18395.6
EPS(TTM)
Face Value()
Div & Yield %
1.13
1
0
 

Bajaj Healthcare appoints Shreekumar Nair as COO
Nov 27,2025
Shreekumar Shankarnarayan Nair holds a bachelor of science degree from SIES College, Mumbai, along with a Diploma in Materials Management from Mumbai University. He brings over 40 years of extensive leadership experience in the pharmaceutical industry, having served in senior roles at Alembic and Glenmark.

His distinguished career reflects a consistent excellence in operational management, process optimization, and supply chain transformation. His deep expertise and proven track record will play a pivotal role in driving our organization towards greater efficiency and enhanced performance.

Bajaj Healthcare specializes in manufacturing of intermediates, API, formulations & Nutraceuticals. The company has state-of-art manufacturing facilities of APIs, intermediates and formulations. These facilities are designed to meet the requirements of both advanced as well as emerging market opportunities.

The company's standalone net profit jumped 17.56% to Rs 11.11 crore on 11.13% rise in revenue from operations to Rs 147.91 crore in Q2 FY26 over Q2 FY25.

The scrip rose 0.06% to end at Rs 425.65 on the BSE.